Abstract
IntrinsiQ Specialty Solutions and ION Solutions, both a part of drug wholesaler AmerisourceBergen, have unveiled the AdvanceIQ Network, a resource for community oncology and urology practices aimed at improving the ability of patients in the community setting to qualify for and enroll in targeted clinical trials.
The new service will be made available to the more than 5,300 community providers that are part of ION Solutions, a physician service organization serving oncology practices, with the aim of reducing the time burden on practices that may prevent them from referring patients for clinical trials.
“The launch of AdvanceIQ Network addresses one of healthcare’s biggest challenges—access. As specialty care continues to grow, it’s critically important we create new pathways, through both innovation and partnerships, to connect patients to cutting-edge therapies found in clinical trials,” said Susan Weidner, senior vice president at IntrinsiQ Specialty Solutions, a provider of medical oncology workflows and data analysis.
Practices in the network select the types of research in which they would like to participate, and will provide access to de-identified patient information to the network. Clinical trial developers can search AdvanceIQ to find practices treating patients who meet specific trial criteria.
asiseeit/ Getty Images
